Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/18/2002
 
First Published:
1/1/2000
1.
Phase II Study of Rosiglitazone in Patients With Liposarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
DFCI-99083
NCI-G99-1629, NCT00004180
Last Modified:
6/13/2008
 
First Published:
11/22/2004
2.
Phase II Pilot Study of Rosiglitazone in Patients With Locoregionally Extensive or Metastatic Differentiated Thyroid Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCSF-03201
UCSF-H28355-22994-01, GSK-UCSF-H28355-22994-01, NCT00098852
3.
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Other
050416
NCT00178841
Last Modified:
10/1/2007
 
First Published:
8/18/2006
4.
Phase II Chemoprevention Study of Rosiglitazone in Patients With High-Risk Hyperplastic or Dysplastic Oral Leukoplakia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Prevention
Completed
18 and over
NCI
MSKCC-05062
MDA-2005-0485, MDA04-2-02, NCT00369174
Last Modified:
4/7/2006
 
First Published:
5/28/2004
5.
Randomized Pilot Study of Celecoxib and Rosiglitazone in Patients With Early-Stage Non-Invasive Carcinoma of the Bladder Undergoing Cystoscopic Surveillance and in Patients With Muscle-Invasive Carcinoma of the Bladder Undergoing Radical Cystectomy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Completed
18 and over
NCI
FCCC-03018
NCT00084578
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute